Home Data Calendar Blog

RMTI

Tables

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Weighted Average Number Of Diluted Shares Outstanding 18.5018.36NA10.538.810.77NA8.458.438.42NA6.466.256.08NANANANANANANA4.62NA4.614.594.56NA4.564.564.56NA4.524.514.47NA3.643.603.58NA3.542.811.91NA1.871.851.75NA1.611.58NANANANA
Weighted Average Number Of Shares Outstanding Basic 18.5018.36NA10.538.810.77NA8.458.438.42NA6.466.256.08NANANANANANANA4.62NA4.614.594.56NA4.564.564.56NA4.524.514.47NA3.643.603.58NA3.542.811.91NA1.871.851.75NA1.611.58NANANANA
Earnings Per Share Basic -0.18-0.10-0.14-0.40-0.56-9.33-1.00-0.89-1.00-0.89-1.00-1.11-1.11-1.33NANANANANANANA-1.44-2.00-1.11-1.56-1.00-1.11-1.00-1.22-1.11-1.33-0.56-0.56-0.78-1.67-1.11-0.89-2.22NA-3.78-4.22-8.00NA-9.56-6.44-6.00NA-3.11-2.89-1.89NA-0.440.11
Earnings Per Share Diluted -0.18-0.10-0.14-0.40-0.56-9.33-1.00-0.89-1.00-0.89-1.00-1.11-1.11-1.33NANANANANANANA-1.44-2.00-1.11-1.56-1.00-1.11-1.00-1.22-1.11-1.33-0.56-0.56-0.78-1.67-1.11-0.89-2.22NA-3.78-4.22-8.00NA-9.56-6.44-6.00NA-3.11-2.89-1.89NA-0.440.11

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenue From Contract With Customer Including Assessed Tax 18.0819.6719.3118.6918.6816.1215.3315.9915.1415.4715.1615.2815.9015.8615.4915.4114.8515.5616.8516.6714.9114.9514.8414.6313.2414.5913.3912.8113.4513.6314.1314.3812.9613.8814.4513.7413.0312.9613.9613.0912.9812.3413.0012.6912.1212.0311.9011.9811.8013.2914.3214.7515.51
Revenues 18.0819.6719.3118.6918.6816.1215.3315.9915.1415.4715.1615.2815.9015.8615.4915.4114.8515.5616.8516.6714.9114.9514.8414.6313.2414.5913.3912.8113.4513.6314.1314.3812.9613.8814.4513.7413.0312.9613.9613.0912.9812.3413.0012.6912.1212.0311.9011.9811.8013.2914.3214.7515.51
Cost Of Goods And Services Sold 17.0517.0716.9717.9116.9416.9117.5616.3215.4015.0714.7814.9315.0214.7414.3815.4214.1114.5515.6714.7018.9315.6716.0613.5611.74NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Gross Profit 1.032.602.340.781.75-0.79-2.23-0.33-0.260.400.390.350.881.111.11-0.020.731.011.181.97-4.020.03-1.221.071.502.361.991.581.491.692.062.502.072.312.582.272.021.682.061.631.691.281.701.651.721.631.541.381.071.652.382.402.77
Research And Development Expense 0.170.28NA0.470.931.57NA1.222.421.81NA1.751.621.82NA1.472.960.501.610.811.561.672.131.301.681.211.201.262.061.312.031.250.890.801.681.300.194.625.7910.6110.2212.7511.7516.2410.889.417.874.223.312.401.740.730.44
General And Administrative Expense 3.293.253.803.254.783.823.873.883.683.924.423.622.875.274.664.625.506.227.616.045.533.12NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Selling And Marketing Expense 0.530.500.350.760.530.460.871.541.471.852.131.672.002.071.901.832.223.100.290.120.160.22NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Income Loss -2.96-1.43-1.97-3.71-4.48-6.63-8.36-6.97-7.82-7.18-8.07-6.69-5.60-8.05-7.40-7.94-10.37-8.81-9.42-5.00-12.30-6.70-9.22-5.03-6.72-4.96-5.26-4.75-5.59-4.61-6.06-2.57-2.65-3.81-5.02-3.13-2.38-7.03-7.53-12.36-11.78-15.39-13.68-17.92-11.98-10.68-8.96-5.12-4.62-3.00-1.82-0.760.11
Interest Expense 0.400.390.440.480.480.540.590.610.580.580.590.670.520.100.010.020.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Interest Paid Net 0.000.290.210.260.540.460.510.340.500.480.650.500.330.08NANA0.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 0.310.190.220.180.10-0.180.390.360.43-0.240.750.25-1.460.931.060.881.501.521.960.611.370.451.151.642.11NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss -3.31-1.75-2.36-4.19-4.97-7.16-8.94-7.58-8.40-7.75-8.66-7.35-6.89-7.98-7.30-7.86-10.29-8.68-9.38-4.97-12.23-6.53-9.04-5.06-7.08-4.74-5.05-4.56-5.36-4.82-5.77-2.41-2.54-3.70-6.38-3.97-3.17-7.81-8.33-13.21-11.86-15.38-13.67-17.88-11.91-10.57-8.95-5.04-4.54-2.91-1.66-0.740.12
Comprehensive Income Net Of Tax -3.32-1.76-2.25-4.18-4.97-7.16-8.95-7.58-8.40-7.76-8.65-7.35-6.90-7.98-7.32-7.85-10.28-8.69-9.36-4.83-12.09-6.72-9.03-4.81-6.58-4.63-5.35-4.45-5.12-4.87-6.11-2.68-2.72-3.63-6.57-4.03-3.19-7.77-8.30-13.20-11.86-15.38-13.65-17.73-11.90-10.47-8.87-5.53-4.51-2.90NANANA
Net Income Loss Available To Common Stockholders Basic -3.31-1.75NANA-4.97-7.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss Available To Common Stockholders Diluted -3.31-1.75NANA-4.97-7.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets 38.0440.4746.6354.1959.1237.4448.5758.7063.6869.4577.7585.2458.5866.8344.3248.0957.0848.7552.5638.0841.4251.9658.7865.8169.4880.4683.1582.8587.1489.1087.8290.9291.5397.1698.0023.8725.8826.7936.3643.6054.0317.9717.0324.2234.0939.4231.9434.5934.10NA36.97NANA
Liabilities 28.5127.9332.5338.0538.9742.2446.0447.6045.4843.2743.5843.1642.3745.0524.0024.3827.4828.5825.2825.4124.5323.5925.87NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Liabilities And Stockholders Equity 38.0440.4746.6354.1959.1237.4448.5758.7063.6869.4577.7585.2458.5866.8344.3248.0957.0848.7552.5638.0841.4251.9658.7865.8169.4880.4683.1582.8587.1489.1087.8290.9291.5397.1698.0023.8725.8826.7936.3643.6054.0317.9717.0324.2234.0939.4231.9434.5934.10NA36.97NANA
Stockholders Equity 9.5312.5414.1116.1420.14-4.812.5411.0918.2026.1834.1742.0816.2121.7720.3223.7029.5920.1627.2812.6716.8927.3732.9140.7943.8550.6152.9655.7657.6360.2162.3264.4365.9967.8268.70-5.46-3.91-3.530.606.1017.24-10.51-9.961.1716.6725.5918.2424.9627.73NA30.54NANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets Current 27.5729.6935.3142.3647.2424.8035.2946.0852.4059.2469.4777.9451.5459.4936.8740.5648.2640.1946.8332.0935.5344.2548.8361.1963.8074.7578.5179.7883.9885.7684.6387.9088.4494.0194.7119.8921.7022.3431.9238.9449.2614.1913.1520.0029.4033.8425.9028.1030.27NA32.67NANA
Cash And Cash Equivalents At Carrying Value 8.9610.8910.1012.9830.789.9113.2823.3932.3835.6748.6856.6126.7037.4011.7914.4221.4220.9222.714.291.753.288.413.898.3311.9017.1819.2923.8230.0131.2033.1737.1563.3365.803.022.860.6611.8821.2140.955.774.711.176.4713.645.728.429.327.9512.2623.6624.20
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 8.9610.8910.1012.9830.789.9113.2823.3932.3835.6748.6856.6126.7037.4011.7914.4221.4220.9222.714.29NANA8.41NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accounts Receivable Net Current 5.416.026.267.378.097.125.916.045.366.604.174.133.574.594.205.125.396.716.987.585.355.996.365.374.887.256.398.037.596.225.055.903.944.674.474.194.224.104.584.224.584.464.434.324.364.224.224.264.50NA4.51NANA
Inventory Net 5.815.595.815.025.175.534.084.034.684.123.913.884.564.293.653.583.974.004.044.654.528.547.6414.8613.7713.4212.1411.7611.019.167.877.426.325.203.922.982.782.912.802.812.922.872.652.672.762.412.502.232.36NA2.94NANA
Prepaid Expense And Other Assets Current 1.481.241.752.413.202.232.862.811.412.392.712.623.461.762.982.863.671.681.901.662.47NA1.78NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Available For Sale Securities Debt Securities 5.915.9411.39NANANA9.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Property Plant And Equipment Gross 10.069.979.839.759.639.589.599.519.409.189.189.118.528.478.308.308.198.108.868.8712.04NA11.92NANANA11.07NANANA10.94NANANA10.30NANANA9.77NANANA9.31NANANA9.14NANANANANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 7.967.807.647.487.347.207.107.006.876.716.546.326.216.045.865.795.625.526.226.209.43NA9.37NANANA9.68NANANA9.29NANANA8.80NANANA8.12NANANA7.45NANANA6.85NANANANANANA
Property Plant And Equipment Net 2.092.182.192.262.292.382.492.512.532.472.642.792.312.432.432.512.562.572.642.672.612.572.551.711.531.421.391.511.561.691.651.341.371.401.501.621.651.761.651.711.741.791.861.942.032.132.292.462.60NA3.05NANA
Goodwill 0.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.92NA0.92NANA
Other Assets Noncurrent 0.530.520.520.520.510.620.620.730.630.630.630.630.560.560.430.560.560.560.540.540.490.490.490.490.490.520.500.600.600.600.460.540.540.540.541.071.201.311.371.491.520.440.430.650.991.742.002.270.16NA0.16NANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Liabilities Current 17.4515.0717.6919.3418.5419.5920.9721.7634.0411.2312.7912.7111.5013.3612.3712.3914.8315.7313.2012.6911.238.449.147.627.6710.3910.157.319.188.018.098.477.0310.349.8017.2815.3114.1017.8518.0716.7928.4726.9923.0517.4213.8413.699.626.37NA6.42NANA
Long Term Debt Current 4.633.131.635.135.136.637.387.1321.13NANANANANANANANANANANANANANANANANANANANANANANANANANA7.965.974.112.31NANANANANANANANANANANANANANA
Accounts Payable Current 5.935.204.053.052.944.223.744.834.933.314.164.193.313.123.023.194.074.524.496.933.214.014.224.193.873.945.863.404.984.424.005.224.325.145.295.176.285.138.697.118.3016.1014.838.096.414.665.363.613.22NA3.66NANA
Other Accrued Liabilities Current 1.461.894.201.941.551.881.750.941.081.271.131.851.833.542.971.901.692.543.52NANANA2.32NANANA2.01NANANA1.72NANANA2.22NANANA1.92NANANA1.07NANANA1.42NANANANANANA
Accrued Liabilities Current 3.764.367.705.894.664.375.094.373.994.035.014.974.446.164.523.924.076.275.132.724.044.194.723.233.596.234.213.834.123.493.832.942.584.864.333.822.784.616.6510.128.4612.2912.0214.6910.799.048.235.893.00NA2.58NANA
Contract With Customer Liability Current 0.260.261.732.162.172.162.172.182.172.172.172.182.172.182.232.242.242.252.25NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Long Term Debt Noncurrent 4.746.157.558.9610.3711.7813.1914.09NA21.0420.9520.8620.7620.680.00NANANANANANANANANANANANANANANANANANANANA12.0514.4816.2217.92NANANANANANANANANANANANANANA
Operating Lease Liability Noncurrent 2.022.212.58NANANANANANANA1.821.041.201.561.78NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Stockholders Equity 9.5312.5414.1116.1420.14-4.812.5411.0918.2026.1834.1742.0816.2121.7720.3223.7029.5920.1627.2812.6716.8927.3732.9140.7943.8550.6152.9655.7657.6360.2162.3264.4365.9967.8268.70-5.46-3.91-3.530.606.1017.24-10.51-9.961.1716.6725.5918.2424.9627.73NA30.54NANA
Additional Paid In Capital 403.20402.89402.70402.48402.30372.38372.55372.17371.70371.27371.51370.76337.55336.22326.78322.84NANA299.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Retained Earnings Accumulated Deficit -393.81-390.51-388.76-386.40-382.21-377.24-370.08-361.14-353.56-345.16-337.41-328.74-321.39-314.50-306.52-299.21-291.36-281.07-272.39-263.01-258.04-246.79-240.26-231.22-226.17-219.08-214.34-209.29-204.72-199.36-194.54-188.77-186.35-183.82-180.12-173.73-169.77-166.60-158.79-150.46-137.25-125.39-110.01-96.33-78.46-66.55-55.99-47.03-41.99NA-34.54NANA
Accumulated Other Comprehensive Income Loss Net Of Tax 0.140.160.160.050.050.050.050.060.050.050.060.050.050.050.050.070.070.060.060.05-0.09-0.23-0.04-0.04-0.29-0.79-0.90-0.60-0.72-0.96-0.92-0.58-0.31-0.13-0.20-0.010.050.070.03NANANANA-0.03-0.18-0.18-0.28-0.36-0.17NA-0.21NANA
Stock Issued During Period Value New Issues NANANANA14.92NANANANANANANANA8.00NANANANANANANANA0.01NANANA0.000.000.000.082.560.020.630.9268.930.590.571.040.170.1637.9412.150.060.00-0.0616.250.450.08NANANANANA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities -1.74-3.88-0.59-1.10-5.91-9.81-9.03-7.08-4.94-12.49-8.57-4.92-9.65-6.50-5.35-6.18-10.35-5.42-5.80-4.77-5.24-4.60-4.81-4.05-7.10-5.150.54-6.70-5.23-1.07-2.70-3.84-6.39-3.3117.560.31-3.25-10.37-8.14-9.69-21.53-11.31-7.17-8.79-6.48-8.30-3.53-2.29-0.40-4.560.83-0.42NA
Net Cash Provided By Used In Investing Activities -0.065.303.22-14.70-0.059.130.54-1.361.65-0.510.641.87-1.892.590.17-1.14-7.363.582.207.323.72-0.529.32-0.515.82-0.13-2.652.16-0.96-0.20-0.48-0.16-20.43-0.07-11.17-0.184.88-2.33-2.16-10.18-0.16-0.1510.463.30-2.15-0.09-0.07-0.14-0.17-0.20-12.24-0.17NA
Net Cash Provided By Used In Financing Activities -0.13-0.63-5.50-2.0026.82-2.69-1.62-0.55NANA-0.0032.960.8029.562.500.3218.210.0522.01NANANA0.010.12NANA0.000.000.000.081.200.020.630.9256.400.030.571.470.970.1356.8612.520.250.201.4716.310.901.541.930.450.020.05NA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities -1.74-3.88-0.59-1.10-5.91-9.81-9.03-7.08-4.94-12.49-8.57-4.92-9.65-6.50-5.35-6.18-10.35-5.42-5.80-4.77-5.24-4.60-4.81-4.05-7.10-5.150.54-6.70-5.23-1.07-2.70-3.84-6.39-3.3117.560.31-3.25-10.37-8.14-9.69-21.53-11.31-7.17-8.79-6.48-8.30-3.53-2.29-0.40-4.560.83-0.42NA
Net Income Loss -3.31-1.75-2.36-4.19-4.97-7.16-8.94-7.58-8.40-7.75-8.66-7.35-6.89-7.98-7.30-7.86-10.29-8.68-9.38-4.97-12.23-6.53-9.04-5.06-7.08-4.74-5.05-4.56-5.36-4.82-5.77-2.41-2.54-3.70-6.38-3.97-3.17-7.81-8.33-13.21-11.86-15.38-13.67-17.88-11.91-10.57-8.95-5.04-4.54-2.91-1.66-0.740.12
Depreciation Depletion And Amortization 0.170.160.150.140.140.140.130.150.180.200.220.210.200.210.210.200.190.190.180.190.150.130.130.130.130.130.180.190.200.200.210.200.200.210.230.260.250.260.260.250.250.250.260.270.280.280.250.280.320.330.340.34NA
Increase Decrease In Accounts Receivable -0.61-0.24-1.11-0.720.971.21-0.120.68-1.242.430.040.56-1.020.38-0.92-0.27-1.32-0.27-0.602.23NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Inventories NA-0.221.18-0.14-0.391.460.10-0.240.380.420.35-0.350.470.83-0.02-0.230.10-0.164.50-2.36-1.25-0.06-2.73-0.140.242.292.210.751.851.290.461.101.121.280.940.20-0.130.11-0.01-0.100.050.22-0.02-0.090.35-0.090.27-0.12-0.42-0.150.40-0.33NA
Increase Decrease In Accounts Payable 0.721.151.000.11-1.280.48-1.09-0.101.62-0.85-0.040.880.190.10-0.18-0.87-0.460.03-2.443.72-0.81-0.210.030.32-0.07-1.912.46-1.580.560.43-1.230.90-0.82-0.160.12-1.111.14-3.551.57-1.19-7.801.276.741.681.75-0.701.760.390.52-0.960.82-0.60NA
Share Based Compensation 0.310.190.220.180.10-0.180.390.360.43-0.240.750.25-1.460.931.060.881.501.521.960.610.701.111.071.572.042.262.552.572.542.682.791.101.703.293.801.892.232.171.401.671.431.351.251.331.191.201.040.891.081.050.990.88NA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Investing Activities -0.065.303.22-14.70-0.059.130.54-1.361.65-0.510.641.87-1.892.590.17-1.14-7.363.582.207.323.72-0.529.32-0.515.82-0.13-2.652.16-0.96-0.20-0.48-0.16-20.43-0.07-11.17-0.184.88-2.33-2.16-10.18-0.16-0.1510.463.30-2.15-0.09-0.07-0.14-0.17-0.20-12.24-0.17NA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Financing Activities -0.13-0.63-5.50-2.0026.82-2.69-1.62-0.55NANA-0.0032.960.8029.562.500.3218.210.0522.01NANANA0.010.12NANA0.000.000.000.081.200.020.630.9256.400.030.571.470.970.1356.8612.520.250.201.4716.310.901.541.930.450.020.05NA

    2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenues 18.0819.6719.3118.6918.6816.1215.3315.9915.1415.4715.1615.2815.9015.8615.4915.4114.8515.5616.8516.6714.9114.9514.8414.6313.2414.5913.3912.8113.4513.6314.1314.3812.9613.8814.4513.7413.0312.9613.9613.0912.9812.3413.0012.6912.1212.0311.9011.9811.8013.2914.3214.7515.51
Concentrate Products 18.0219.6019.1818.4318.1415.9015.0915.7114.8615.1914.8015.0015.6615.6015.2615.2414.7615.4916.7916.6014.8514.88NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue 0.070.070.130.260.550.220.240.280.270.280.360.280.240.260.230.170.080.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Products,US 16.1217.9317.4317.1016.3914.2913.3314.0313.5113.6913.9013.9613.8114.0013.9413.8513.3213.4214.3413.7113.3612.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Products, Non Us 1.891.671.751.331.751.621.761.681.351.500.901.041.851.611.331.391.452.072.452.891.48NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue,US NANA0.000.190.210.160.180.220.210.230.300.230.180.200.160.100.010.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue, Non Us 0.070.070.130.070.340.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product License Fee,US, Transferred Over Time 0.001.47NA0.480.480.48NA0.480.480.48NA0.490.490.49NA0.490.490.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales,US, Transferred At Point In Time 16.1216.4616.3816.6215.9113.8112.8513.5413.0313.2013.4113.4713.3213.5113.4413.3512.8212.92NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales, Non Us, Transferred At Point In Time 1.891.671.751.331.751.621.761.681.351.500.901.041.851.611.331.391.452.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug License Fee, Non Us, Transferred Over Time 0.070.070.060.070.070.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales,US, Transferred At Point In Time NANA0.000.190.210.160.180.220.210.230.300.230.180.200.160.100.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales, Non Us, Transferred At Point In Time NANA0.070.000.27NANANANANANANA0.000.00NANA0.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product License Fee, Transferred Over Time 0.001.47NA0.480.480.48NA0.480.480.48NA0.490.490.49NA0.490.490.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales, Transferred At Point In Time 18.0218.1318.1317.9517.6615.4314.6115.2214.3814.7114.3114.5115.1715.1114.7714.7514.2715.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug License Fee, Transferred Over Time 0.070.070.060.070.070.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales, Transferred At Point In Time NANA0.070.190.480.160.180.220.210.230.300.230.180.200.160.100.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
US 16.1217.9317.4317.2916.5914.4513.5114.2413.7313.9114.2014.1913.9914.2014.1013.9513.3313.4214.3413.7113.3612.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Non Us 1.961.741.881.402.091.681.821.751.411.560.961.091.911.661.401.461.512.142.522.961.55NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Including Assessed Tax 18.0819.6719.3118.6918.6816.1215.3315.9915.1415.4715.1615.2815.9015.8615.4915.4114.8515.5616.8516.6714.9114.9514.8414.6313.2414.5913.3912.8113.4513.6314.1314.3812.9613.8814.4513.7413.0312.9613.9613.0912.9812.3413.0012.6912.1212.0311.9011.9811.8013.2914.3214.7515.51
Concentrate Products 18.0219.6019.1818.4318.1415.9015.0915.7114.8615.1914.8015.0015.6615.6015.2615.2414.7615.4916.7916.6014.8514.88NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue 0.070.070.130.260.550.220.240.280.270.280.360.280.240.260.230.170.080.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Products,US 16.1217.9317.4317.1016.3914.2913.3314.0313.5113.6913.9013.9613.8114.0013.9413.8513.3213.4214.3413.7113.3612.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Products, Non Us 1.891.671.751.331.751.621.761.681.351.500.901.041.851.611.331.391.452.072.452.891.48NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue,US NANA0.000.190.210.160.180.220.210.230.300.230.180.200.160.100.010.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Revenue, Non Us 0.070.070.130.070.340.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product License Fee,US, Transferred Over Time 0.001.47NA0.480.480.48NA0.480.480.48NA0.490.490.49NA0.490.490.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales,US, Transferred At Point In Time 16.1216.4616.3816.6215.9113.8112.8513.5413.0313.2013.4113.4713.3213.5113.4413.3512.8212.92NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales, Non Us, Transferred At Point In Time 1.891.671.751.331.751.621.761.681.351.500.901.041.851.611.331.391.452.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug License Fee, Non Us, Transferred Over Time 0.070.070.060.070.070.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales,US, Transferred At Point In Time NANA0.000.190.210.160.180.220.210.230.300.230.180.200.160.100.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales, Non Us, Transferred At Point In Time NANA0.070.000.27NANANANANANANA0.000.00NANA0.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product License Fee, Transferred Over Time 0.001.47NA0.480.480.48NA0.480.480.48NA0.490.490.49NA0.490.490.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Concentrate Product Sales, Transferred At Point In Time 18.0218.1318.1317.9517.6615.4314.6115.2214.3814.7114.3114.5115.1715.1114.7714.7514.2715.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug License Fee, Transferred Over Time 0.070.070.060.070.070.060.060.060.060.060.060.060.060.060.070.070.070.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Sales, Transferred At Point In Time NANA0.070.190.480.160.180.220.210.230.300.230.180.200.160.100.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
US 16.1217.9317.4317.2916.5914.4513.5114.2413.7313.9114.2014.1913.9914.2014.1013.9513.3313.4214.3413.7113.3612.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Non Us 1.961.741.881.402.091.681.821.751.411.560.961.091.911.661.401.461.512.142.522.961.55NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Goodwill
Assets
Goodwill
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
Shares
Common Stock Shares Issued
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four
InventoryNet
Inventory Work In Process Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical
('rmti:ConcentrateProducts', None)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:StatementGeographical
('rmti:ConcentrateProducts', None)
Revenuesus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')
Revenuesus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')
Revenuesus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AccountsReceivableNetCurrent
us-gaap:MajorCustomers, us-gaap:ConcentrationRiskByBenchmark
(None, 'us-gaap:AccountsReceivable')
Accounts Receivable Net Currentus-gaap: Major Customers, us-gaap: Concentration Risk By Benchmark
us-gaap:InventoryNet
us-gaap:PublicUtilitiesInventory
(None,)
Inventory Netus-gaap: Public Utilities Inventory
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:SubsidiarySaleOfStock
(None,)
Stock Issued During Period Value New Issuesus-gaap: Subsidiary Sale Of Stock
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents, us-gaap:SubsidiarySaleOfStock
('us-gaap:AdditionalPaidInCapital', None)
Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components, us-gaap: Subsidiary Sale Of Stock
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:StatementGeographical
('rmti:ConcentrateProducts', None)
Revenuesus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')
Revenuesus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')
Revenuesus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical
('rmti:ConcentrateProducts', None)
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')
Revenue From Contract With Customer Including Assessed Taxus-gaap: Product Or Service, us-gaap: Timing Of Transfer Of Good Or Service